{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":2,"sponsored":0,"items":[{"id":"n_zcj3kdzmhnc3skkuazaa","seq":1535615,"kind":"article","title":"Analyzing Fate Therapeutics (NASDAQ:FATE) and Syndax Pharmaceuticals (NASDAQ:SNDX)","url":"https://www.themarketsdaily.com/2026/10/03/analyzing-fate-therapeutics-nasdaqfate-and-syndax-pharmaceuticals-nasdaqsndx.html","published":"2026-10-03T13:06:23Z","seen":"2026-10-03T13:06:23Z","lang":"en","source":{"id":"themarketsdaily.com","name":"themarketsdaily.com","domain":"themarketsdaily.com"},"via":"gdelt-gkg-english","topics":["economy","business","health"],"authors":["Tristan Rich"],"entities":[{"id":"Q30287119","name":"Fate Therapeutics","type":"org"},{"id":"Q112085354","name":"Syndax Pharmaceuticals","type":"org"}],"story":"st_zcj3kdzmhnc3skkuazaa","category":"economy-business","category_p":0.59,"sentiment":"neutral","tone":0.46,"political":0.02},{"id":"n_rinnrnf4krofsbiy2mia","seq":1327496,"kind":"press_release","title":"Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)","url":"https://www.globenewswire.com/news-release/2026/10/02/3373739/24675/en/fate-therapeutics-reports-new-employee-inducement-awards-under-nasdaq-listing-rule-5635-c-4.html","summary":"SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on October 1, 2026, the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 62,900 shares of the…","published":"2026-10-02T11:00:00Z","seen":"2026-10-02T11:17:05Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business","nasdaq:fate","us31189p1021"],"entities":[{"id":"Q30287119","name":"Fate Therapeutics","type":"org"}],"mentions":2,"story":"st_rinnrnf4krofsbiy2mia","category":"economy-business","category_p":0.68,"sentiment":"positive","tone":0.5,"political":0.02}]}